Access with Evidence Development Schemes: A Framework for Description and Evaluation

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.28, Iss.2, 2010-02, pp. : 143-152

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Access with Evidence Development: The US Experience

By Mohr Penny E. Tunis Sean R.

PharmacoEconomics, Vol. 28, Iss. 2, 2010-02 ,pp. : 153-162

Adis International

Access to resources Recommend Favorite

Access with Evidence Development in the UK: Past Experience, Current Initiatives and Future Potential

By Briggs Andrew

PharmacoEconomics, Vol. 28, Iss. 2, 2010-02 ,pp. : 163-170

Adis International

Access to resources Recommend Favorite

Widening Access to Treatment for Alcohol Misuse: Description and Formative Evaluation of an Innovative Web-Based Service in One Primary Care Trust

By Murray Elizabeth Linke Stuart Harwood Elissa Conroy Sophie Stevenson Fiona Godfrey Christine

Alcohol and Alcoholism, Vol. 47, Iss. 6, 2012-11 ,pp. : 697-701

Oxford University Press

Access to resources Recommend Favorite

Principles of Design of Access with Evidence Development Approaches: A Consensus Statement from the Banff Summit

By Menon Devidas

PharmacoEconomics, Vol. 28, Iss. 2, 2010-02 ,pp. : 109-111

Adis International

Access to resources Recommend Favorite

Are UK patient access schemes working?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 610, 2010-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite